当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析 - 现金流量表

华海药业

(600521)

  

流通市值:241.66亿  总市值:241.66亿
流通股本:14.97亿   总股本:14.97亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,861,207,741.242,486,694,087.38,709,986,888.796,615,578,877.09
  收到的税费返还138,042,500.9864,777,189.24216,564,223.97111,725,483.41
  收到其他与经营活动有关的现金151,444,07138,527,999.18245,623,358.44173,991,588.18
  经营活动现金流入小计5,150,694,313.222,589,999,275.729,172,174,471.26,901,295,948.68
  购买商品、接受劳务支付的现金1,659,326,187867,948,925.112,607,895,934.192,515,392,005.49
  支付给职工以及为职工支付的现金979,894,020.56559,971,235.221,865,521,482.471,377,650,514.37
  支付的各项税费342,090,467.9172,558,207.83608,004,159.62498,566,565.7
  支付其他与经营活动有关的现金1,071,333,581.69590,888,293.982,860,664,326.031,857,300,190.98
  经营活动现金流出小计4,052,644,257.152,191,366,662.147,942,085,902.316,248,909,276.54
  经营活动产生的现金流量净额1,098,050,056.07398,632,613.581,230,088,568.89652,386,672.14
二、投资活动产生的现金流量:
  收回投资收到的现金2,144,342.95-116,266,648.6116,266,648.6
  取得投资收益收到的现金--2,276,291.74159,980.78
  处置固定资产、无形资产和其他长期资产收回的现金净额25,824,336.324,092,6859,952,0063,042,212.2
  处置子公司及其他营业单位收到的现金净额152,231,347.1---
  收到的其他与投资活动有关的现金--89,150,00075,150,000
  投资活动现金流入小计180,200,026.374,092,685217,644,946.34194,618,841.58
  购建固定资产、无形资产和其他长期资产支付的现金722,467,532.32446,392,949.921,966,048,669.651,184,831,134.49
  投资支付的现金--30,000,00030,000,000
  取得子公司及其他营业单位支付的现金6,530,265.32---
  支付其他与投资活动有关的现金-134,418,652.989,150,00089,150,000
  投资活动现金流出小计728,997,797.64580,811,602.822,085,198,669.651,303,981,134.49
  投资活动产生的现金流量净额-548,797,771.27-576,718,917.82-1,867,553,723.31-1,109,362,292.91
三、筹资活动产生的现金流量:
  吸收投资收到的现金--591,515,088.97591,515,088.97
  取得借款收到的现金1,480,257,765.151,180,000,0004,725,846,856.913,454,074,156.91
  收到其他与筹资活动有关的现金--200,000,000200,000,000
  筹资活动现金流入小计1,480,257,765.151,180,000,0005,517,361,945.884,245,589,245.88
  偿还债务支付的现金1,271,254,853.91507,670,7374,303,857,9183,372,511,383
  分配股利、利润或偿付利息支付的现金246,980,740.437,283,948.28558,051,627.45491,179,385.96
  其中:子公司支付给少数股东的股利、利润23,741,605-11,870,802.511,870,802.5
  支付其他与筹资活动有关的现金13,605,139.7110,400,036.9938,382,608.7724,705,404.28
  筹资活动现金流出小计1,531,840,734.02555,354,722.274,900,292,154.223,888,396,173.24
  筹资活动产生的现金流量净额-51,582,968.87624,645,277.73617,069,791.66357,193,072.64
四、汇率变动对现金及现金等价物的影响-106,848,032.89-47,290,591.29-10,650,693.14-10,772,784.36
五、现金及现金等价物净增加额390,821,283.04399,268,382.2-31,046,055.9-110,555,332.49
  加:期初现金及现金等价物余额1,446,554,164.111,446,554,164.111,477,600,220.011,477,600,220.01
  期末现金及现金等价物余额1,837,375,447.151,845,822,546.311,446,554,164.111,367,044,887.52
补充资料:
  净利润767,088,108.01-227,329,393.11-
  资产减值准备18,906,386.57-205,463,675.96-
  固定资产和投资性房地产折旧481,960,560.97-888,153,436.39-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧481,960,560.97-888,153,436.39-
  无形资产摊销64,040,393.5-123,310,912.26-
  长期待摊费用摊销5,968,923.47-13,238,385.18-
  处置固定资产、无形资产和其他长期资产的损失-23,330,595.34--943.66-
  固定资产报废损失1,608,207.68-13,497,071.17-
  公允价值变动损失-9,596,469.37--48,739,845.24-
  财务费用216,660,637.19-267,297,570.98-
  投资损失-211,124,981.07--20,710,977.24-
  递延所得税8,691,195.79--5,107,155.12-
  其中:递延所得税资产减少8,691,195.79--5,107,155.12-
  存货的减少98,743,736.31--471,605,242.36-
  经营性应收项目的减少37,635,444.26--126,337,241.49-
  经营性应付项目的增加-373,490,689.92-165,021,079.43-
  其他7,444,968.45-8,312,103.96-
  现金的期末余额1,837,375,447.15-1,446,554,164.11-
  减:现金的期初余额1,446,554,164.11-1,477,600,220.01-
  现金及现金等价物的净增加额390,821,283.04--31,046,055.9-
公告日期2026-08-272026-04-302026-04-302025-10-31
审计意见(境内)标准无保留意见
TOP↑